U.S. Residential REITs Stock News

Integra LifeSciences Holdings Corporation reported past second-quarter 2026 results showing sales of US$418.76 million and net income of US$4.48 million, a shift from a large net loss a year earlier. The company also modestly reduced its full-year 2026 reported revenue outlook due to currency headwinds while reaffirming its organic revenue growth and adjusted EPS guidance, underscoring the effect of foreign exchange on reported performance. We’ll now examine how this earnings improvement,...

Recently, analyst reports highlighted that TJX Companies raised its FY2027 guidance, pointing to 3%–4% comparable sales growth and higher EPS expectations, while also receiving a Zacks Rank #2 and a Momentum Style Score of B amid upward earnings estimate revisions for the current and next fiscal years. This combination of stronger earnings expectations and improved momentum signals that investors are increasingly focused on whether TJX’s off-price model can consistently translate robust...

SolarEdge Technologies (SEDG) just combined three meaningful updates that matter for investors. The company released Q2 2026 results, issued Q3 revenue guidance, and highlighted fresh progress with its Nexis home energy platform. See our latest analysis for SolarEdge Technologies. Despite SolarEdge Technologies reporting narrower losses for Q2 2026 and outlining Q3 revenue guidance, the share price has fallen 22.91% over the past week and 42.44% over the past month. Over a 1 year period, the...

In late July 2026, UDR, Inc. reported second-quarter 2026 results showing net income of US$69.04 million and basic earnings per share from continuing operations of US$0.21, both higher than the same period a year earlier, while revenue was broadly unchanged at about US$425.40 million. Alongside these results, UDR raised its full-year 2026 net income guidance per diluted share to a range of US$1.03 to US$1.11, signaling management’s increased confidence in the company’s earnings...

Leidos Holdings (LDOS) reported second quarter 2026 results with higher sales but lower net income, raised its full year revenue outlook, and highlighted a series of recent defense and intelligence contract wins. See our latest analysis for Leidos Holdings. Leidos Holdings' latest news arrives after a sharp rebound in the share price, with a 7 day share price return of 19.01% and a 30 day share price return of 28.55%. This comes even though the year to date share price return is down 25.02%...

Mattel, Inc. reported past second-quarter 2026 results with sales rising to US$1,125.3 million from US$1,018.6 million a year earlier, but shifting from a net income of US$53.4 million to a net loss of US$18.2 million, while six-month net income improved to US$42.8 million. Alongside these mixed earnings, Mattel completed a substantial share repurchase of 18,353,965 shares for US$298.31 million, potentially altering its capital structure and per-share metrics. We’ll now examine how Mattel’s...

Recent commentary around Chewy (CHWY) has sharpened focus on the stock’s valuation and profitability pressures, drawing fresh attention as investors weigh its mixed return history against ongoing interest in pet e commerce. See our latest analysis for Chewy. Chewy’s recent 1 month share price return of 12.69% and 7 day share price return of 4.12% suggest some momentum is returning, although the year to date share price return has declined 29.74% and the 5 year total shareholder return has...

In early August 2026, AMD, Spectro Cloud and Supermicro launched AMD Instinct Coder, a turnkey enterprise AI inference stack built on Instinct MI325X GPUs, Spectro Cloud’s PaletteAI software and Supermicro’s pre-validated server systems to simplify and accelerate private AI deployment. This move highlights AMD’s push beyond chips into full-stack, hybrid AI solutions that can shift routine workloads to local models while keeping access to premium frontier models for complex tasks. We’ll now...

Why Etsy Stock Is Back in Focus After Q2 Earnings Etsy (ETSY) is in the spotlight after second quarter results on August 5, 2026, along with a raised full year outlook, a new US$2b share repurchase plan, and a workforce restructuring. See our latest analysis for Etsy. The recent Q2 report, higher full year outlook and new US$2b buyback have come alongside a strong run in Etsy's share price, with a 90 day share price return of 42.92% and a 1 year total shareholder return of 40.45%, while the 5...

FB Financial stock has delivered a strong 86.8% return over the past three years, while the latest Excess Returns intrinsic value estimate suggests the shares trade at a discount to fair value even though broader valuation checks lean cautious. That mix leaves investors weighing a stock that has already performed well against signals that it may still be pricing in a margin of safety. FB Financial's 86.8% return over three years points to a stock that has already rewarded shareholders and...

Boardroom Changes Put Kohl's Governance In Focus Kohl's (KSS) is back on investor radars after a boardroom reshuffle, with long serving director John E. Schlifske retiring as independent Chair and Wendy Arlin stepping into the role on July 28, 2026. The company also added experienced consumer brands executive Niren Chaudhary to its Board, giving investors fresh information to consider around governance, oversight and how board composition might influence future decisions at the retailer. See...

Why Hepsiburada’s Latest Earnings Are Drawing Investor Attention D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS), known as Hepsiburada, has come under closer investor focus after unaudited Q2 2026 results showed higher sales together with a much wider net loss and weaker EBITDA. The company reported Q2 sales of TRY 22,810.91 million compared with TRY 22,120.30 million a year earlier, while net loss increased to TRY 1,889.59 million from TRY 956.25 million as spending on marketing,...

Helmerich & Payne (HP) drew fresh attention after reporting fiscal Q3 2026 results that came in above its own guidance, along with a higher full-year North America rig-count outlook and a continued focus on debt reduction. See our latest analysis for Helmerich & Payne. At a share price of $37.10, Helmerich & Payne has seen a 30 day share price return of 11.31% and a year to date share price return of 23.91%, while the 1 year total shareholder return of 122.62% contrasts with a modest 3 year...

Carlisle Companies dividend hike and guidance raise put capital returns in focus Carlisle Companies (CSL) has drawn fresh attention after reporting record second quarter results, raising full year revenue guidance to mid single digit growth and lifting its 2026 share repurchase target to $1.2b. At the same time, the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share, or $5 on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of...

Why QuinStreet’s latest earnings and M&A comments matter for investors QuinStreet (QNST) has put itself firmly on investors’ radars after reporting detailed fourth quarter and full year 2026 results, alongside new fiscal 2027 revenue guidance and fresh commentary on potential acquisitions. The company reported fourth quarter sales of US$373.88 million and net income of US$19.11 million. For the full 2026 fiscal year, sales were US$1.29b with net income of US$81.24 million, according to the...

AtriCure (ATRC) has drawn investor attention after multiple insider share sales. This followed a quarter in which the company reported 13% second quarter revenue growth, a return to net income, and raised full year guidance. See our latest analysis for AtriCure. AtriCure’s recent insider sales come against a backdrop of strong share price momentum, with a 57.38% 90 day share price return and 20.74% 30 day share price return, while the 5 year total shareholder return is still down 43.49%. If...

GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15. For the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile. We’ll now examine how this widening net...

Pediatrix Medical Group has delivered a strong 89.0% share price return over the past year, yet the stock still screens as cheap on several valuation checks. This raises the question of how much of the recent improvement is already reflected in the price. The recent share price drop following earnings news adds another layer for investors weighing whether the current level still offers value. Over the last 1 year, Pediatrix Medical Group shares are up 89.0%. This means anyone looking at the...

Axsome Therapeutics event context and recent stock performance Axsome Therapeutics (AXSM) continues to draw investor attention as it advances therapies for central nervous system disorders, including approved treatments for depression, excessive daytime sleepiness, and migraine, alongside multiple late stage clinical programs. The stock last closed at US$212.74 on 7 August 2026. Over the past month the share price declined 9%, while the past 3 months show a smaller fall of 1.7%, leaving the...

Expro (XPRO) updated investors with higher full year 2026 revenue guidance and fresh quarterly targets, following softer second quarter results and a completed share buyback that reduced the share count by 2.2%. See our latest analysis for Expro. The guidance update and buyback arrive after a mixed stretch for Expro, with a 24.34% year to date share price return and a 64.98% total shareholder return over one year, but a 26.93% total shareholder return decline over three years. Recent 7 day...

What the latest earnings mean for Organogenesis Holdings stock Organogenesis Holdings (ORGO) is back in focus after second quarter results showed sharply lower revenue and a much wider net loss, alongside a deeper revenue outlook cut and a planned US$75 million equity raise. The earnings update matters for you because it reshapes expectations on cash generation, dilution risk and how much flexibility Organogenesis Holdings might have to fund its wound care portfolio, including products like...

Weaker US job numbers, softer wage growth, and fading odds of a September Fed hike have put major bank stocks under a sharper spotlight. When the labor market cools and rate expectations shift, the ripple effects can matter for profits, loan quality, and investor confidence. This article walks through three large US bank stocks that appear especially exposed to this latest data, and explains why that may give you a reason to reassess your own banking exposure today. Wells Fargo...

Why the new First Plus mandate matters for SS&C Technologies SS&C Technologies Holdings (SSNC) has been selected by First Plus Asset Management Pte. Ltd. to support around US$200 million in cross-border assets across Asia, covering transfer agency, order management, execution, and investment accounting. This new client adds to SS&C Technologies Holdings' global operations footprint and gives investors fresh information about how its integrated service model is being used across multiple Asian...

Joby Aviation (JOBY) is back in focus after a busy week, with the stock reacting to raised 2026 revenue guidance, a new 45,000 square foot Texas facility, and a fresh vertiport partnership with Atoms. See our latest analysis for Joby Aviation. The latest facility opening and vertiport partnership have come alongside a 7 day share price return of 20.84% and a 1 day move of 4.98%. However, Joby Aviation’s year to date share price return is still down 39.83% and the 1 year total shareholder...